This webinar recording aims to improve the understanding and management of pancreatic exocrine insufficiency (PEI) and pancreatic enzyme replacement therapy (PERT) for people affected by pancreatic cancer. This session will provide evidence-based, quality information for health professionals who provide care for people with upper gastro-intestinal (GI) cancers, including oncologists, GPs, gastroenterologists and allied health professionals. The panel includes: Dr Mehrdad Nikfarjam | Lauren Atkins, Oncology Dietician | Chris C, consumer | Professor John Zalcberg The expert panel will discuss: What is pancreatic exocrine insufficiency (PEI) and pancreatic enzyme replacement therapy (PERT)? Use of PERT for people living with pancreatic cancer: after pancreatectomy, after Whipples , non-resectable Recommendation for patients: dosage, how to take pancreatic enzymes and side effects Patient sharing lived experience Who should prescribe PERT? Frequently asked questions Visit pancare.org.au for more information.